Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs Leflunomide for BK Virus Infection in Kidney Transplant Recipients
NCT04542733Active, not recruiting
- Start
- Jun 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of everolimus and leflunomide in BK virus infection (2 arms). Primary endpoint: Plasma BK viral load change at 6 months. Started Jun 2023; status: active, not recruiting.
02
Drugs
everolimusleflunomide
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT04542733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542733.